This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Feldkamp, J. Articles by Scherbaum, W. A. Search for Related Content PubMed PubMed Citation Articles by Feldkamp, J. Articles by Scherbaum, W. A.

Soluble Fas Is Increased in Hyperthyroidism Independent of the Underlying Thyroid Disease

Departments of Endocrinology and Surgery (P.G.), Heinrich Heine University, D-40225 Dusseldorf, Germany; and German Diabetes Research Institute (J.S.), D-40225, Dusseldorf, Germany

Address all correspondence and requests for reprints to: Joachim Feldkamp, M.D., Department of Endocrinology, Heinrich Heine University, Moorenstrasse 5, D-40225 Dusseldorf, Germany. E-mail feldkamj{at}uni-duesseldorf.de

Abstract

In Hashimoto’s thyroiditis, Fas-induced apoptosis is one of the mechanisms leading to cell destruction, whereas thyroid tissue in Graves’ disease is prevented from it. The soluble form of the Fas molecule produced by alternative splicing prevents from apoptosis. We measured soluble Fas in the sera of 112 patients with Graves’ disease, 21 patients with toxic goiter, and 24 patients with subclinical hyperthyroidism due to suppressive therapy with levothyroxine after near-total resection of the thyroid gland for nodular goiter.

Soluble Fas was increased in thyrotoxic patients, toxic goiter, and patients with subclinical hyperthyroidism. Decreased levels of soluble Fas were found in euthyroid patients with Graves’ disease after surgery, whereas soluble Fas was normal in euthyroid patients with Graves’ disease receiving antithyroid drug treatment and in patients in stable remission. There was a good correlation between soluble Fas with free T₃ (r = 0.6) and free T₄ (r = 0.5). Our results show that soluble Fas is increased in hyperthyroidism independent of the underlying thyroid disease.

This article has been cited by other articles:

				S. Fountoulakis, G. Vartholomatos, N. Kolaitis, S. Frillingos, G. Philippou, and A. Tsatsoulis Differential expression of Fas system apoptotic molecules in peripheral lymphocytes from patients with Graves' disease and Hashimoto's thyroiditis. Eur. J. Endocrinol., June 1, 2008; 158(6): 853 - 859. [Abstract] [Full Text] [PDF]